Literature DB >> 22595958

Plasma renin activity and the aldosterone-to-renin ratio are associated with the development of chronic kidney disease: the Ohasama Study.

Shiho Terata1, Masahiro Kikuya, Michihiro Satoh, Takayoshi Ohkubo, Takanao Hashimoto, Azusa Hara, Takuo Hirose, Taku Obara, Hirohito Metoki, Ryusuke Inoue, Kei Asayama, Atsuhiro Kanno, Kazuhito Totsune, Haruhisa Hoshi, Hiroshi Satoh, Hiroshi Sato, Yutaka Imai.   

Abstract

BACKGROUND: The aldosterone-to-renin ratio (ARR) is used to screen for primary aldosteronism and could be an index for salt sensitivity. The association between ARR and the development of chronic kidney disease (CKD) is completely unknown.
METHOD: A longitudinal observational study involving 689 participants from a general Japanese population (mean age 58.2 years; 68.5% women) who did not have CKD and were not receiving antihypertensive medication at baseline was conducted. The estimated glomerular filtration rate (eGFR) was calculated from serum creatinine levels, and CKD was defined as eGFR less than 60 ml/min per 1.73 m(2) and/or dipstick-positive proteinuria. The associations of baseline plasma renin activity (PRA), plasma aldosterone concentration, and ARR with the development of CKD were examined using Cox proportional hazard regression analysis adjusted for sex, age, BMI, smoking, drinking, history of hypercholesterolemia, diabetes mellitus, and cardiovascular disease, SBP, and baseline eGFR.
RESULTS: During a mean 9.1-year follow-up, 118 participants developed CKD. A 1 standard deviation increment in the natural log-transformed (ln) ARR was positively associated with the incidence of CKD (hazard ratio 1.29, P = 0.012). LnPRA showed an inverse association (hazard ratio 0.76, P = 0.007). Meanwhile, plasma aldosterone concentration was not associated with CKD. Individuals who developed CKD had significantly lower baseline PRA (0.97 vs. 1.14 ng/ml per h; P = 0.03) and higher baseline ARR levels [66.6 vs. 56.8 (pg/ml)/(ng/ml per h); P = 0.02] than those who did not.
CONCLUSIONS: Lower PRA and higher ARR were associated with the development of CKD in a general population, suggesting that they are independent predictors of CKD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22595958     DOI: 10.1097/HJH.0b013e328354f65b

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  14 in total

1.  Aldosterone-to-renin ratio acts as the predictor distinguishing the primary aldosteronism from chronic kidney disease.

Authors:  Wei-Guo Chen; Ting-Ting Zhou; Peng Zhou; Xiao-Wei Li; Zhun Wu; Kai-Yan Zhang; Jin-Chun Xing
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

2.  Association between the urinary sodium-to-potassium ratio and renal outcomes in patients with chronic kidney disease: a prospective cohort study.

Authors:  Yuta Matsukuma; Masaru Nakayama; Susumu Tsuda; Akiko Fukui; Ryota Yoshitomi; Kazuhiko Tsuruya; Toshiaki Nakano; Takanari Kitazono
Journal:  Hypertens Res       Date:  2021-09-03       Impact factor: 3.872

3.  Elevated galectin-3 precedes the development of CKD.

Authors:  Conall M O'Seaghdha; Shih-Jen Hwang; Jennifer E Ho; Ramachandran S Vasan; Daniel Levy; Caroline S Fox
Journal:  J Am Soc Nephrol       Date:  2013-06-13       Impact factor: 10.121

4.  Lipocalin-2 derived from adipose tissue mediates aldosterone-induced renal injury.

Authors:  Wai Yan Sun; Bo Bai; Cuiting Luo; Kangmin Yang; Dahui Li; Donghai Wu; Michel Félétou; Nicole Villeneuve; Yang Zhou; Junwei Yang; Aimin Xu; Paul M Vanhoutte; Yu Wang
Journal:  JCI Insight       Date:  2018-09-06

5.  Aldosterone and glomerular filtration--observations in the general population.

Authors:  Anke Hannemann; Rainer Rettig; Kathleen Dittmann; Henry Völzke; Karlhans Endlich; Matthias Nauck; Henri Wallaschofski
Journal:  BMC Nephrol       Date:  2014-03-10       Impact factor: 2.388

6.  Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels.

Authors:  Christina M Gant; Gozewijn D Laverman; Liffert Vogt; Maartje C J Slagman; Hiddo J L Heerspink; Femke Waanders; Marc H Hemmelder; Gerjan Navis
Journal:  BMC Nephrol       Date:  2017-12-20       Impact factor: 2.388

7.  Relation of multi-marker panel to incident chronic kidney disease and rapid kidney function decline in African Americans: the Jackson Heart Study.

Authors:  Stanford E Mwasongwe; Bessie Young; Aurelian Bidulescu; Mario Sims; Adolfo Correa; Solomon K Musani
Journal:  BMC Nephrol       Date:  2018-09-20       Impact factor: 2.388

8.  Responses of the renin-angiotensin-aldosterone system in pregnant chronic kidney disease patients with and without superimposed pre-eclampsia.

Authors:  Lesia O Kurlak; Fiona Broughton Pipkin; Markus G Mohaupt; Hiten D Mistry
Journal:  Clin Kidney J       Date:  2019-03-25

9.  Plasma renin activity, serum aldosterone concentration and selected organ damage indices in essential arterial hypertension.

Authors:  Tomasz Pizoń; Marek Rajzer; Wiktoria Wojciechowska; Tomasz Drożdż; Dorota Drożdż; Marta Rojek; Krystian Gruszka; Danuta Czarnecka
Journal:  Arch Med Sci       Date:  2018-02-07       Impact factor: 3.318

10.  Association of the ratio of visceral-to-subcutaneous fat volume with renal function among patients with primary aldosteronism.

Authors:  Tatsuya Haze; Moe Hatakeyama; Shiro Komiya; Rina Kawano; Yuki Ohki; Shota Suzuki; Yusuke Kobayashi; Akira Fujiwara; Sanae Saka; Kouichi Tamura; Nobuhito Hirawa
Journal:  Hypertens Res       Date:  2021-08-06       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.